Mid-Year Report — 340B HEALTH for 340B HEALTH (2007)

Firm

340B HEALTH

Client

340B HEALTH

Income

—

Expenses

$200,000

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

16. Specific Lobbying Issues: Proposed guidelines from the Health Resources & Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA). Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of Children's Hospitals to the 340B Program, physician administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement & Integrity Act of 2007 (S. 1376/H.R 2606),

Lobbyist	Covered position, as disclosed
TED KORNOBIS	N/A
EDITH MARSHALL	N/A
JONNI MCCRANN	SENIOR LEGISLATIVE ASSISTANT
TED SLAFSKY	N/A
WILLIAM VON OEHSEN	N/A
COURTNEY YOHE	N/A

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Health Resources & Services Administration (HRSA)

Bills named: H.R. 2606 (110th), S. 1376 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.